« Federal judge in Alabama orders mediation for Chantix lawsuits not yet settled | Main | Omontys recall forces Affymax to ax 75% of workforce, weigh bankruptcy »

March 14, 2013

FDA Conducting Safety Review Of Certain Diabetes Drugs

Quoted from http://online.wsj.com/article/BT-CO-20130314-709260.html

FDA Conducting Safety Review Of Certain Diabetes Drugs

By Jennifer Corbett Dooren

  • March 14, 2013, 11:46 a.m. ET

WASHINGTON--The U.S. Food and Drug Administration Thursday said it is reviewing information about a class of diabetes drugs that suggests they might cause pre-cancerous changes in the pancreas.

Such drugs involve newer types of Type 2 diabetes medicines that include Bristol-Myers Squibb Co.'s (BMY) Byetta, Bydureon and Onglyza; Novo Nordisk A/S's (NVO) Victoza; Merck & Co.'s (MRK) Januvia; and Eli Lilly & Co.'s (LLY) Tradjenta. The pancreas is a gland that produces several hormones and enzymes, including insulin.

The labels on the drugs currently warn of an increased risk of pancreatitis, or inflammation of the pancreas, but the suggestion of pre-cancerous changes in the pancreas is new. However, the FDA stressed that it hasn't concluded that the medicines "may cause or contribute to the development of pancreatic cancer."

[Article continues at original source]

Related articles
Newest Diabetes Drugs Linked to Higher Pancreatitis Risk

Posted at 01:33 PM in Bydureon, Byetta, Januvia, Onglyza, Tradjenta, Victoza |

Tags: Bristol-Myers Squibb Co, Bydureon, Byetta, diabetes drugs, drug injury, Eli Lilly & Co, FDA warning, Januvia, Merck & Co, Onglyza; Novo Nordisk, panceatic cancer, pancreatitis, safety review, side effects, Tradjenta, Victoza

Comments

Search Engine

  • Google

    WWW
    www.drug-injury.com

Patient Advisory

  • The prescription drugs discussed on this site are approved for use by the the Food and Drug Administration (FDA). Patients should not stop taking any prescription drug without seeking the advice of their medical doctor. This site is not affiliated with any of the drug companies or the FDA.

Quick Contact Form

  • In a rush? You can use our Quick Contact Form to tell us the basic facts about your case.

Free Case Evaluation


  • We encourage you to submit a Drug Injury Legal Case Evaluation – it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible drug injury case. Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, nor some other lawyer — about your case based on his many years of experience handling drug injury lawsuits.

Drug Injury Watch

Thank You For Reading


Subscribe to Lamb Law Office Newsletter

Subscribe to our Lamb Law Office Newsletter for periodic updates about some of the cases we are working on for clients. We include, also, an information resource you might find helpful in each Newsletter.

* indicates required